![]() |
|||||||||||
Testing Adaptive Physical Activity in Stroke
This study is currenly Recruiting patients.
Sponsored by:
Baltimore VA Medical Center
Purpose
"Testing Adaptive Physical Activity in Stroke" tests the idea that adaptive physical
activity (APA) will improve fitness, balance and walking function, daily step activity, and
outcomes related to quality of life in individuals with chronic stroke. Adaptive physical
activity is an exercise model that combines aerobic exercise with balance and gait training
in a socially reinforcing group setting. Individualized homework assignments encourage
integration of exercise into daily life routines. Our specific aims are:
1. to determine whether APA improves cardiovascular fitness and metabolic health
2. to measure the effects of APA on gait and balance, ambulatory activity, and ADL
function
3. to determine whether APA affects self-reported outcomes related to self-efficacy,
fatigue, and stroke-specific quality of life
Study Type: Intervention
Study Design:Allocation: Randomized, Control: Historical Control, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Official Title: Testing Adaptive Physical Activity in Stroke
Further Study Details:
Expected Total Enrollment:
Study Dates:September 2008 -
Eligibility
Ages Eligible for Study- Min: 40 Years Max: N/A
Gender: Both
Criteria
Inclusion Criteria: 1. Ischemic stroke greater than or equal to 6 months prior in men or women ages 40- or older. Hemorrhagic stroke greater than or equal to one year prior in men or women ages 40-or older. 2. Residual hemiparetic gait deficits. 3. Already completed all conventional inpatient and outpatient physical therapy. 4. Adequate language and neurocognitive function to participate in exercise testing and training (specific screening instruments used.)
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier: NCT01042990
Maryland
Baltimore VAMC - Baltimore, Maryland 21201
Kathleen M Michael, PhD 410-605-7000 kmichael@grecc.umaryland.edu
More Information
Record Last Reviewed:December 2009
Last Updated:January 5, 2010
Record First Recieved:January 5, 2010
ClinicalTrials.gov Identifier:NCT01042990
Health Authority: United States Food and Drug Administration
Information obtained from ClinicalTrials.gov on September 02, 2010
|
|
||||||||||